PMID- 32333014 OWN - NLM STAT- MEDLINE DCOM- 20210910 LR - 20210910 IS - 1529-7268 (Electronic) IS - 0006-3363 (Linking) VI - 103 IP - 1 DP - 2020 Jun 23 TI - MicroRNA-21 as a regulator of human cumulus cell viability and its potential influence on the developmental potential of the oocyte. PG - 94-103 LID - 10.1093/biolre/ioaa058 [doi] AB - MicroRNA-21 is expressed in bovine, murine, and human cumulus cells with its expression in murine and bovine cumulus cells correlated with oocyte developmental potential. The aim of this study was to assess the relationship between cumulus cell MIR-21 and human oocyte developmental potential. These studies revealed that both the immature and mature forms of MicroRNA-21 (MIR-21-5p) were elevated in cumulus cells of oocytes that developed into blastocysts compared to cumulus cells of oocytes that arrested prior to blastocyst formation. This increase in MicroRNA-21 was observed regardless of whether the oocytes developed into euploid or aneuploid blastocysts. Moreover, MIR-21-5p levels in cumulus cells surrounding oocytes that either failed to mature or matured to metaphase II but failed to fertilize, were approximately 50% less than the MIR-21-5p levels associated with oocytes that arrested prior to blastocyst formation. Why cumulus cells associated with oocytes of reduced developmental potential expressed less MIR-21-5p is unknown. It is unlikely due to reduced expression of either the receptors of growth differentiation factor 9 or rosha Ribonuclease III (DROSHA) and Dicer Ribonuclease III (DICER) which sequentially promote the conversion of immature forms of MicroRNA-21 to mature MicroRNA-21. Furthermore, cultured cumulus cells treated with a MIR-21-5p inhibitor had an increase in apoptosis and a corresponding increase in the expression of PTEN, a gene known to inhibit the AKT-dependent survival pathway in cumulus cells. These studies provide evidence for a role of MicroRNA-21 in human cumulus cells that influences the developmental potential of human oocytes. CI - (c) The Author(s) 2020. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. FAU - Bartolucci, Alison F AU - Bartolucci AF AD - Department of Obstetrics and Gynecology, Farmington, CT 06030, USA. AD - The Center for Advanced Reproductive Services, University of Connecticut Health Center, Farmington, CT 06030, USA. FAU - Uliasz, Tracy AU - Uliasz T AD - Department of Cell Biology, University of CT Health Center, Farmington, CT 06030, USA. FAU - Peluso, John J AU - Peluso JJ AD - Department of Obstetrics and Gynecology, Farmington, CT 06030, USA. AD - Department of Cell Biology, University of CT Health Center, Farmington, CT 06030, USA. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Biol Reprod JT - Biology of reproduction JID - 0207224 RN - 0 (MIRN21 microRNA, human) RN - 0 (MicroRNAs) RN - EC 3.1.3.67 (PTEN Phosphohydrolase) RN - EC 3.1.3.67 (PTEN protein, human) SB - IM MH - Adult MH - Apoptosis/drug effects MH - Blastocyst/physiology MH - Cell Survival/physiology MH - Cells, Cultured MH - Cumulus Cells/drug effects/*physiology MH - Embryo Culture Techniques MH - Female MH - Gene Expression MH - Humans MH - MicroRNAs/antagonists & inhibitors/genetics/*physiology MH - Oocytes/*growth & development MH - PTEN Phosphohydrolase/genetics MH - Sperm Injections, Intracytoplasmic OTO - NOTNLM OT - apoptosis OT - blastocyst OT - oocyte-follicle interactions EDAT- 2020/04/26 06:00 MHDA- 2021/09/11 06:00 CRDT- 2020/04/26 06:00 PHST- 2020/01/21 00:00 [received] PHST- 2020/03/18 00:00 [revised] PHST- 2020/04/22 00:00 [accepted] PHST- 2020/04/26 06:00 [pubmed] PHST- 2021/09/11 06:00 [medline] PHST- 2020/04/26 06:00 [entrez] AID - 5824829 [pii] AID - 10.1093/biolre/ioaa058 [doi] PST - ppublish SO - Biol Reprod. 2020 Jun 23;103(1):94-103. doi: 10.1093/biolre/ioaa058.